{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T02:25:54Z","timestamp":1781144754992,"version":"3.54.1"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,27]],"date-time":"2022-01-27T00:00:00Z","timestamp":1643241600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Regenerative Therapy"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.reth.2022.01.008","type":"journal-article","created":{"date-parts":[[2022,2,17]],"date-time":"2022-02-17T17:40:33Z","timestamp":1645119633000},"page":"158-165","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Safety study of allogeneic mesenchymal stem cell therapy in animal model"],"prefix":"10.1016","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9400-558X","authenticated-orcid":false,"given":"Alvin Man Lung","family":"Chan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5791-639X","authenticated-orcid":false,"given":"Angela Min Hwei","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6793-2043","authenticated-orcid":false,"given":"Mohd Heikal","family":"Mohd Yunus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruszymah Bt","family":"Hj Idrus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9045-5145","authenticated-orcid":false,"given":"Jia Xian","family":"Law","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6162-4405","authenticated-orcid":false,"given":"Muhammad Dain","family":"Yazid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kok-Yong","family":"Chin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharen Aini","family":"Shamsuddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohd Rafizul","family":"Mohd Yusof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2712-4348","authenticated-orcid":false,"given":"Rabiatul Adawiyah","family":"Razali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohd Asyraf","family":"Mat Afandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Najib Fathi","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"See Nguan","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benson","family":"Koh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9548-6490","authenticated-orcid":false,"given":"Yogeswaran","family":"Lokanathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.reth.2022.01.008_bib1","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1002\/jcb.21957","article-title":"Taking stem cells to the clinic: major challenges","volume":"105","author":"Bongso","year":"2008","journal-title":"J\u00a0Cell Biochem"},{"issue":"4","key":"10.1016\/j.reth.2022.01.008_bib2","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/14653240600855905","article-title":"Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement","volume":"8","author":"Dominici","year":"2006","journal-title":"Cytotherapy"},{"issue":"2","key":"10.1016\/j.reth.2022.01.008_bib3","doi-asserted-by":"crossref","first-page":"218","DOI":"10.15283\/ijsc18034","article-title":"Mesenchymal stem cells from the wharton's jelly of the human umbilical cord: biological properties and therapeutic potential","volume":"12","author":"Marino","year":"2019","journal-title":"Int J Stem Cells"},{"key":"10.1016\/j.reth.2022.01.008_bib4","doi-asserted-by":"crossref","first-page":"591693","DOI":"10.3389\/fped.2020.591693","article-title":"The potential of mesenchymal stromal cell as therapy in neonatal diseases","volume":"8","author":"Liau","year":"2020","journal-title":"Front Pediatr"},{"key":"10.1016\/j.reth.2022.01.008_bib5","first-page":"9529465","article-title":"Large-scale expansion of human mesenchymal stem cells","volume":"2020","author":"Hassan","year":"2020","journal-title":"Stem Cell Int"},{"issue":"4","key":"10.1016\/j.reth.2022.01.008_bib6","doi-asserted-by":"crossref","first-page":"825","DOI":"10.17576\/jsm-2020-4904-12","article-title":"Mesenchymal stem cell therapy for sports injuries \u2013 from research to clinical practice","volume":"49","author":"Looi","year":"2020","journal-title":"Sains Malays"},{"issue":"4","key":"10.1016\/j.reth.2022.01.008_bib7","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/cmi.2014.70","article-title":"Immunogenicity of allogeneic mesenchymal stem cells transplanted via different routes in diabetic rats","volume":"12","author":"Gu","year":"2015","journal-title":"Cell Mol Immunol"},{"issue":"3","key":"10.1016\/j.reth.2022.01.008_bib8","first-page":"267","article-title":"Stem cell therapy for cardiac arrhythmias","volume":"6","author":"Mocini","year":"2005","journal-title":"Ital Heart J"},{"issue":"2","key":"10.1016\/j.reth.2022.01.008_bib9","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.ccep.2015.03.012","article-title":"Arrhythmia in stem cell transplantation","volume":"7","author":"Almeida","year":"2015","journal-title":"Card Electrophysiol Clin"},{"issue":"1","key":"10.1016\/j.reth.2022.01.008_bib10","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1186\/s13287-019-1295-9","article-title":"Bone marrow vs Wharton's jelly mesenchymal stem cells in experimental sepsis: a comparative study","volume":"10","author":"Laroye","year":"2019","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.reth.2022.01.008_bib11","first-page":"9628536","article-title":"Challenges and controversies in human mesenchymal stem cell therapy","volume":"2019","author":"Lukomska","year":"2019","journal-title":"Stem Cell Int"},{"issue":"3","key":"10.1016\/j.reth.2022.01.008_bib12","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/term.143","article-title":"Phenotypic and functional comparison of optimum culture conditions for upscaling of bone marrow-derived mesenchymal stem cells","volume":"3","author":"Pal","year":"2009","journal-title":"J\u00a0Tissue Eng Regen Med"},{"issue":"4","key":"10.1016\/j.reth.2022.01.008_bib13","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1089\/scd.2007.0217","article-title":"Comparative analysis of mesenchymal stem cells from bone marrow, cartilage, and adipose tissue","volume":"17","author":"Peng","year":"2008","journal-title":"Stem Cell Dev"},{"issue":"19","key":"10.1016\/j.reth.2022.01.008_bib14","first-page":"1783","article-title":"Wharton's jelly mesenchymal stem cells differentiate into retinal progenitor cells","volume":"8","author":"Hu","year":"2013","journal-title":"Neural Regen Res"},{"key":"10.1016\/j.reth.2022.01.008_bib15","first-page":"652034","article-title":"Safety of mesenchymal stem cells for clinical application","volume":"2012","author":"Wang","year":"2012","journal-title":"Stem Cell Int"},{"issue":"3","key":"10.1016\/j.reth.2022.01.008_bib16","doi-asserted-by":"crossref","first-page":"143","DOI":"10.4161\/org.5.3.9811","article-title":"Clinical grade adult stem cell banking","volume":"5","author":"Thirumala","year":"2009","journal-title":"Organogenesis"},{"key":"10.1016\/j.reth.2022.01.008_bib17","first-page":"905621","article-title":"Establishment of a mesenchymal stem cell bank","volume":"2011","author":"Cooper","year":"2011","journal-title":"Stem Cell Int"},{"issue":"1","key":"10.1016\/j.reth.2022.01.008_bib18","first-page":"43","article-title":"Tansplantation of autologous bone marrow derived mesenchymal stem cells trans-epicardially in patients undergoing coronary bypass surgery","volume":"62","author":"Viswanathan","year":"2010","journal-title":"Indian Heart J"},{"issue":"7","key":"10.1016\/j.reth.2022.01.008_bib19","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1002\/stem.1111","article-title":"Are therapeutic human mesenchymal stromal cells compatible with human blood?","volume":"30","author":"Moll","year":"2012","journal-title":"Stem Cell"},{"key":"10.1016\/j.reth.2022.01.008_bib20","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41536-017-0028-x","article-title":"Translational considerations in injectable cell-based therapeutics for neurological applications: concepts, progress and challenges","volume":"2","author":"Amer","year":"2017","journal-title":"NPJ Regen Med"},{"issue":"23","key":"10.1016\/j.reth.2022.01.008_bib21","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1161\/CIRCULATIONAHA.110.955971","article-title":"Differentiation of allogeneic mesenchymal stem cells induces immunogenicity and limits their long-term benefits for myocardial repair","volume":"122","author":"Huang","year":"2010","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.reth.2022.01.008_bib22","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1177\/0963689719837897","article-title":"The pros and cons of mesenchymal stem cell-based therapies","volume":"28","author":"Musia\u0142-Wysocka","year":"2019","journal-title":"Cell Transplant"},{"issue":"7","key":"10.1016\/j.reth.2022.01.008_bib23","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.jcyt.2013.03.005","article-title":"Risk of tumorigenicity in mesenchymal stromal cell-based therapies--bridging scientific observations and regulatory viewpoints","volume":"15","author":"Barkholt","year":"2013","journal-title":"Cytotherapy"},{"issue":"1","key":"10.1016\/j.reth.2022.01.008_bib24","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.cryobiol.2008.04.002","article-title":"Evaluation of the viability and osteogenic differentiation of cryopreserved human adipose-derived stem cells","volume":"57","author":"Liu","year":"2008","journal-title":"Cryobiology"},{"issue":"13","key":"10.1016\/j.reth.2022.01.008_bib25","doi-asserted-by":"crossref","first-page":"5331","DOI":"10.1158\/0008-5472.CAN-08-4630","article-title":"Long-term cultures of bone marrow-derived human mesenchymal stem cells frequently undergo spontaneous malignant transformation","volume":"69","author":"R\u00f8sland","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.reth.2022.01.008_bib26","doi-asserted-by":"crossref","first-page":"17892","DOI":"10.1038\/srep17892","article-title":"Ultra-sensitive detection of tumorigenic cellular impurities in human cell-processed therapeutic products by digital analysis of soft agar colony formation","volume":"5","author":"Kusakawa","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.reth.2022.01.008_bib27","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.reth.2014.12.001","article-title":"Characterization of in\u00a0vivo tumorigenicity tests using severe immunodeficient NOD\/Shi-scid IL2R\u03b3null mice for detection of tumorigenic cellular impurities in human cell-processed therapeutic products","volume":"1","author":"Kusakawa","year":"2015","journal-title":"Regen Ther"},{"key":"10.1016\/j.reth.2022.01.008_bib28","series-title":"Characterization of the cell growth analysis for detection of immortal cellular impurities in human mesenchymal stem cells","first-page":"146","volume":"43","author":"Kono","year":"2015"},{"issue":"12","key":"10.1016\/j.reth.2022.01.008_bib29","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/j.jcyt.2016.08.003","article-title":"MSCs can be differentially isolated from maternal, middle and fetal segments of the human umbilical cord","volume":"18","author":"Lim","year":"2016","journal-title":"Cytotherapy"},{"issue":"10","key":"10.1016\/j.reth.2022.01.008_bib30","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.17576\/jsm-2019-4810-12","article-title":"Human platelet lysate promotes proliferation but fails to maintain chondrogenic markers of chondrocytes","volume":"48","author":"Budi Harto","year":"2019","journal-title":"Sains Malays"},{"issue":"8","key":"10.1016\/j.reth.2022.01.008_bib31","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.17576\/jsm-2021-5008-18","article-title":"Expired platelet concentrate as a source of human platelet lysate for Xenogeneic-free culture of human dermal fibroblasts","volume":"50","author":"Hassan","year":"2021","journal-title":"Sains Malays"},{"issue":"3","key":"10.1016\/j.reth.2022.01.008_bib32","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.3390\/ijms22031269","article-title":"Feasibility of human platelet lysate as an alternative to foetal bovine serum for in\u00a0vitro expansion of chondrocytes","volume":"22","author":"Liau","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"6","key":"10.1016\/j.reth.2022.01.008_bib33","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.17576\/jsm-2021-5006-18","article-title":"Immunomodulatory properties of Wharton's jelly-derived mesenchymal stem cells from three anatomical segments of umbilical cord","volume":"50","author":"Lim","year":"2021","journal-title":"Sains Malays"},{"issue":"2","key":"10.1016\/j.reth.2022.01.008_bib34","first-page":"27","article-title":"A\u00a0simple practice guide for dose conversion between animals and human","volume":"7","author":"Nair","year":"2016","journal-title":"J\u00a0Basic Clin Pharm"},{"issue":"11","key":"10.1016\/j.reth.2022.01.008_bib35","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1161\/CIRCRESAHA.117.311827","article-title":"Dose comparison study of allogeneic mesenchymal stem cells in patients with ischemic cardiomyopathy (the TRIDENT study)","volume":"121","author":"Florea","year":"2017","journal-title":"Circ Res"},{"issue":"9","key":"10.1016\/j.reth.2022.01.008_bib36","first-page":"FF01","article-title":"Safety assessment of human bone marrow-derived mesenchymal stromal cells transplantation in wistar rats","volume":"11","author":"Aithal","year":"2017","journal-title":"J\u00a0Clin Diagn Res"},{"issue":"5","key":"10.1016\/j.reth.2022.01.008_bib37","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1159\/000492558","article-title":"Treatment efficiency of different routes of bone marrow-derived mesenchymal stem cell injection in rat liver fibrosis model","volume":"48","author":"Idriss","year":"2018","journal-title":"Cell Physiol Biochem"},{"issue":"2","key":"10.1016\/j.reth.2022.01.008_bib38","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0301-2115(96)02390-1","article-title":"Collagen and glycosaminoglycans of Wharton's jelly and their alterations in EPH-gestosis","volume":"66","author":"Ba\u0144kowski","year":"1996","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"2","key":"10.1016\/j.reth.2022.01.008_bib39","doi-asserted-by":"crossref","first-page":"195","DOI":"10.4252\/wjsc.v6.i2.195","article-title":"Umbilical cord-derived mesenchymal stem cells: their advantages and potential clinical utility","volume":"6","author":"Nagamura-Inoue","year":"2014","journal-title":"World J Stem Cell"},{"issue":"1","key":"10.1016\/j.reth.2022.01.008_bib40","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.retram.2019.09.001","article-title":"Characteristics and clinical applications of Wharton's Jelly-derived mesenchymal stromal cells","volume":"68","author":"Liau","year":"2020","journal-title":"Curr Res Translat Med"},{"issue":"2","key":"10.1016\/j.reth.2022.01.008_bib41","first-page":"189","article-title":"Stvolovye osteogennye kletki kostnogo mozga [Osteogenic stem cells of the bone marrow]","volume":"22","author":"AIa","year":"1991","journal-title":"Ontogenez"},{"key":"10.1016\/j.reth.2022.01.008_bib42","series-title":"Vital statistics, Malaysia","author":"Mahidin","year":"2020"},{"issue":"2","key":"10.1016\/j.reth.2022.01.008_bib43","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1006\/faat.1996.0022","article-title":"Harmonization of animal clinical pathology testing in toxicity and safety studies. The Joint scientific committee for international harmonization of clinical Pathology testing","volume":"29","author":"Weingand","year":"1996","journal-title":"Fund Appl Toxicol"},{"issue":"1","key":"10.1016\/j.reth.2022.01.008_bib44","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s13287-019-1262-5","article-title":"A\u00a0preclinical study-systemic evaluation of safety on mesenchymal stem cells derived from human gingiva tissue","volume":"10","author":"Zhao","year":"2019","journal-title":"Stem Cell Res Ther"},{"issue":"5","key":"10.1016\/j.reth.2022.01.008_bib45","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.physbeh.2010.03.011","article-title":"Hypothalamic mechanisms in cachexia","volume":"100","author":"Grossberg","year":"2010","journal-title":"Physiol Behav"},{"issue":"3","key":"10.1016\/j.reth.2022.01.008_bib46","first-page":"282","article-title":"Identification of markers for imminent death in mice used in longevity and aging research","volume":"49","author":"Ray","year":"2010","journal-title":"J\u00a0Am Assoc Lab Anim Sci"},{"issue":"6","key":"10.1016\/j.reth.2022.01.008_bib47","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/nrn3745","article-title":"Neurobiology of food intake in health and disease","volume":"15","author":"Morton","year":"2014","journal-title":"Nat Rev Neurosci"},{"issue":"2","key":"10.1016\/j.reth.2022.01.008_bib48","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1177\/0300985815610391","article-title":"Cause-of-Death analysis in rodent aging studies","volume":"53","author":"Snyder","year":"2016","journal-title":"Vet Pathol"},{"issue":"1","key":"10.1016\/j.reth.2022.01.008_bib49","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.bbmt.2012.07.019","article-title":"Prevention of nausea and vomiting associated with stem cell transplant: results of a prospective, randomized trial of aprepitant used with highly emetogenic preparative regimens","volume":"19","author":"Stiff","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"issue":"5","key":"10.1016\/j.reth.2022.01.008_bib50","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/bmt.2015.331","article-title":"Adverse reactions during stem cell infusion in children treated with autologous and allogeneic stem cell transplantation","volume":"51","author":"Truong","year":"2016","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"10.1016\/j.reth.2022.01.008_bib51","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/scrt446","article-title":"A\u00a0preliminary evaluation of efficacy and safety of Wharton's jelly mesenchymal stem cell transplantation in patients with type 2 diabetes mellitus","volume":"5","author":"Liu","year":"2014","journal-title":"Stem Cell Res Ther"},{"issue":"3","key":"10.1016\/j.reth.2022.01.008_bib52","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.3892\/etm.2016.3544","article-title":"Long term effect and safety of Wharton's jelly-derived mesenchymal stem cells on type 2 diabetes","volume":"12","author":"Hu","year":"2016","journal-title":"Exp Ther Med"},{"issue":"12","key":"10.1016\/j.reth.2022.01.008_bib53","first-page":"1625","article-title":"Human umbilical cord matrix-derived stem cells exert trophic effects on \u03b2-cell survival in diabetic rats and isolated islets","volume":"8","author":"Zhou","year":"2015","journal-title":"Dis Model Mech"},{"issue":"11","key":"10.1016\/j.reth.2022.01.008_bib54","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/j.jcyt.2013.06.013","article-title":"Co-transplantation of mesenchymal stromal cells and cord blood cells in treatment of diabetes","volume":"15","author":"Xiao","year":"2013","journal-title":"Cytotherapy"},{"issue":"1","key":"10.1016\/j.reth.2022.01.008_bib55","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1590\/S1807-59322007000100011","article-title":"Autopsy-proven causes of death in lungs of patients immunocompromised by secondary interstitial pneumonia","volume":"62","author":"Terrabuio Junior","year":"2007","journal-title":"Clinics"},{"issue":"9","key":"10.1016\/j.reth.2022.01.008_bib56","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20182455","article-title":"Mesenchymal stem cells significantly improved treatment effects of Linezolid on severe pneumonia in a rabbit model","volume":"39","author":"Kong","year":"2019","journal-title":"Biosci Rep"},{"issue":"1","key":"10.1016\/j.reth.2022.01.008_bib57","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1177\/0300985813505117","article-title":"Safety biomarkers in preclinical development: translational potential","volume":"51","author":"Sasseville","year":"2014","journal-title":"Vet Pathol"},{"key":"10.1016\/j.reth.2022.01.008_bib58","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s12931-015-0288-1","article-title":"Prospectively defined murine mesenchymal stem cells inhibit Klebsiella pneumoniae-induced acute lung injury and improve pneumonia survival","volume":"16","author":"Hackstein","year":"2015","journal-title":"Respir Res"},{"issue":"4","key":"10.1016\/j.reth.2022.01.008_bib59","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.ijrobp.2018.04.007","article-title":"Decorin-modified umbilical cord mesenchymal stem cells (MSCs) attenuate radiation-induced lung injuries via regulating inflammation, fibrotic factors, and immune responses","volume":"101","author":"Liu","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.reth.2022.01.008_bib60","doi-asserted-by":"crossref","first-page":"206","DOI":"10.3349\/ymj.2017.58.1.206","article-title":"Angiopoietin-1 modified human umbilical cord mesenchymal stem cell therapy for endotoxin-induced acute lung injury in rats","volume":"58","author":"Huang","year":"2017","journal-title":"Yonsei Med J"},{"issue":"1","key":"10.1016\/j.reth.2022.01.008_bib61","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/s41536-020-00105-z","article-title":"Insights into the use of mesenchymal stem cells in COVID-19 mediated acute respiratory failure","volume":"5","author":"Durand","year":"2020","journal-title":"NPJ Regen Med"},{"key":"10.1016\/j.reth.2022.01.008_bib62","first-page":"4236973","article-title":"Mesenchymal stem cell-based therapy of inflammatory lung diseases: current understanding and future perspectives","volume":"2019","author":"Harrell","year":"2019","journal-title":"Stem Cell Int"}],"container-title":["Regenerative Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352320422000086?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352320422000086?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T17:38:43Z","timestamp":1762450723000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352320422000086"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":62,"alternative-id":["S2352320422000086"],"URL":"https:\/\/doi.org\/10.1016\/j.reth.2022.01.008","relation":{},"ISSN":["2352-3204"],"issn-type":[{"value":"2352-3204","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety study of allogeneic mesenchymal stem cell therapy in animal model","name":"articletitle","label":"Article Title"},{"value":"Regenerative Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.reth.2022.01.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Japanese Society for Regenerative Medicine. Production and hosting by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}